Clinical trials for Parkinson Disease in United States

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Study ID: NCT06312176

Sponsor

Merck Sharp & Dohme LLC

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

Study ID: NCT04938817

Sponsor

Merck Sharp & Dohme LLC

Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease

Study ID: NCT06804668

Sponsor

Brigham and Women's Hospital

Dance and Energy Expenditure Among Adults With Parkinson's

Study ID: NCT06425731

Sponsor

Northeastern University

Motor Network Physiology

Study ID: NCT04957095

Sponsor

University of Texas Southwestern Medical Center

Real-Time Levodopa Level Monitoring in Parkinson Disease

Study ID: NCT04735627

Sponsor

University of California, San Diego

Action Regulation Behavioral

Study ID: NCT06489483

Sponsor

University of Texas Southwestern Medical Center

Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst

Study ID: NCT05658302

Sponsor

University of Minnesota

Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease

Study ID: NCT06911229

Sponsor

University of Florida

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Study ID: NCT05635266

Sponsor

Sanguine Biosciences